Nature's Sunshine Products, Inc.
NASDAQ Capital MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Kenneth G. Romanzi
- Full Time Employees
- 806
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Address
- 2901 West Bluegrass Boulevard Lehi UT United States of America 84043
- IPO Date
- Jun 25, 2009
- CIK
- 0000275053
- Website
- naturessunshine.com
- Similar Companies
- Business
- Nature's Sunshine Products, Inc. (NASDAQ: NATR) manufactures and markets a broad range of nutritional supplements and personal care products focused on natural health and wellness; its core offerings include general health products supporting blood sugar, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision; immune support formulations; cardiovascular aids; digestive solutions; personal care items such as oils, lotions, aloe vera gel, herbal shampoos, skin treatments, toothpaste, and cleansers; and weight management products including Power Meal and Super Beets; the company produces over 450 herbal-based dietary supplements, including herbs, vitamins, and minerals, through its state-of-the-art, solar-powered facilities in Utah. Founded in 1972 by Gene and Kristine Hughes in Spanish Fork, Utah, and headquartered in Lehi, Utah, Nature's Sunshine distributes its products via a global direct sales force exceeding 500,000 independent managers, distributors, and customers across more than 40 countries, with key geographic segments encompassing Asia Pacific and Europe (primary revenue source), North America, Latin America/Other, NSP Russia, Central and Eastern Europe, and Synergy WorldWide. Recent developments include the appointment of Kenneth Romanzi as CEO in October 2025 following a leadership transition plan; the relaunch of its revolutionary Power Line in July 2025 targeting the metabolic health crisis; a secondary public offering of common stock priced in June 2025 by selling stockholder Fosun Pharma USA, Inc., with the company granting itself an option to repurchase up to $15 million in shares; renewal of its scholarship fund with the Eccles School of Business in June 2025; and reporting strong third quarter 2025 results in November 2025, underscoring operational resilience amid e-commerce growth in North America and Japan.
Company News
Nature’s Sunshine Products (NASDAQ:NATR) vs. Natural Health Trends (NASDAQ:NHTC) Financial Review
Nature’s Sunshine Targets $1B Sales, 15% EBITDA Margin in Growth Push
Nature's Sunshine Targets $1B Sales, 15% EBITDA Margin in Growth Push
Nature’s Sunshine Products (NASDAQ:NATR) Major Shareholder Prescott Group Capital Managem Purchases 96,000 Shares of Stock
Nature's Sunshine Products, Inc. (NATR) Q2 2026 Earnings Call Transcript
Nature’s Sunshine Products Q2 Earnings Call Highlights
Nature's Sunshine Products Q2 Earnings Call Highlights
Nature's Sunshine Reports Second Quarter 2026 Results
Nature's Sunshine Appoints Ruth Perkins as Executive Vice President and Chief Financial Officer
Nature's Sunshine Appoints Janine Weber as Executive Vice President and President, North America
Nature's Sunshine: A Herbal Engine With Digital Roots Starting To Show
Nature's Sunshine Products Q1 Earnings Call Highlights
Nature's Sunshine Products, Inc. (NATR) Q1 2026 Earnings Call Transcript
Nature's Sunshine Reports Strong First Quarter 2026 Results
Nature's Sunshine Appoints John Hnanicek as Chief Technology Officer
Nature's Sunshine Sets First Quarter 2026 Conference Call for Thursday, May 7, 2026, at 5:00 p.m. ET
Nature's Sunshine May Perform Better Than Expected (Rating Upgrade)
Nature's Sunshine Products: The Rally May Not Be Over
Nature's Sunshine Products, Inc. (NATR) Q4 2025 Earnings Call Transcript
Nature's Sunshine Reports Strong Fourth Quarter and Full Year 2025 Financial Results